These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1065149)
1. [Chemo- and immunotherapy of malignant neoplasms]. Matthias M Z Arztl Fortbild (Jena); 1975 Jun; 69(11):580-4. PubMed ID: 1065149 [No Abstract] [Full Text] [Related]
2. The immunology of cancer: avenues to immunotherapy. Woods AH Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414 [No Abstract] [Full Text] [Related]
3. Malignant tumours and immunity. Schuler D Ther Hung; 1972; 20(3):83-90. PubMed ID: 4121150 [No Abstract] [Full Text] [Related]
4. The immunotherapy of cancer. Parker CW Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047 [No Abstract] [Full Text] [Related]
5. [The strategy of treatment of acute lymphoblastic leukemia. Combination of chemotherapy and immunotherapy: pursuit of remission from 1 to 2 years after stopping chemotherapy]. Mathé G Therapeutique; 1969 Feb; 45(2):154-5. PubMed ID: 5274145 [No Abstract] [Full Text] [Related]
6. [Chemotherapy and attempts at immunotherapy in treatment of acute lymphoid leukemia]. Mathe G Rev Med Suisse Romande; 1972 Jun; 92(6):429-37. PubMed ID: 4508688 [No Abstract] [Full Text] [Related]
8. Immunotherapy for malignant disease. Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519 [No Abstract] [Full Text] [Related]
9. [Current aspects of the treatment of acute leukemia]. Alekseev GA Klin Med (Mosk); 1973 Dec; 51(12):5-9. PubMed ID: 4591758 [No Abstract] [Full Text] [Related]
12. [1st immunologic attempts in the treatment of human malignant tumors]. Mannelli MA Minerva Med; 1977 Apr; 68(19):1301-4. PubMed ID: 854230 [No Abstract] [Full Text] [Related]
13. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man. Mathé G; Hayat M; Amiel JL; Schwarzenberg L; Schneider M; Pouillart P; Cattan A Boll Ist Sieroter Milan; 1971; 50(4):251-9. PubMed ID: 5293498 [No Abstract] [Full Text] [Related]
14. Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy. Mathé G; Schwarzenberg L; Halle-Pannenko O; Simmler MC Ann N Y Acad Sci; 1976; 277(00):467-84. PubMed ID: 826207 [No Abstract] [Full Text] [Related]
15. Rationale of combined modality therapy for cancer. Martin DS; Fugmann R; Stolfi R; Hayworth P Cancer Chemother Rep 2; 1974 Mar; 4(1):13-24. PubMed ID: 4363650 [No Abstract] [Full Text] [Related]
16. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity. Spreafico F; Mantovani A Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217 [No Abstract] [Full Text] [Related]
17. [Immunotherapy of cancer: evolution of concepts and clinical advances]. Baldwin RW Rev Prat; 1980 Jan; 30(5):221-4, 227-8. PubMed ID: 6929557 [No Abstract] [Full Text] [Related]
19. How should clinical data be included in experimental studies of cancer immunology? Gjertsen BT; Bruserud Ø Cancer Immunol Immunother; 2004 Aug; 53(8):677-80. PubMed ID: 15069584 [TBL] [Abstract][Full Text] [Related]